Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Mucositis Pain in Head and Neck Cancer
NCT02277548Completed
- Sponsor
- Abramson Cancer Center
- Start
- May 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in mucositis comparing Lyrica at 300 mg per day with Placebo (2 arms). Primary endpoint: Average/Cumulative Opioid Dose at 18 months. Started May 2014; status: completed.
02
Drugs
pregabalin
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT02277548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277548.